Premenstrual Dysphoric Disorder (PMDD) Market Size, Share, and COVID-19 Impact Analysis by Treatment, Diagnosis, End User, Regions, Company Market Share, and Regional Forecast, 2022-2030

According to the Regional Research Reports, the Global Premenstrual Dysphoric Disorder (PMDD) Market size was valued at a million USD in 2021 and will reach multi-million USD by 2030, at a CAGR of 4.2% from 2022 to 2030.

Premenstrual dysphoric disorder (PMDD) is a more severe form of premenstrual syndrome (PMS). PMS causes bloating, headaches, and breast tenderness a week or two before the period. With PMDD, a person might have PMS symptoms along with extreme irritability, anxiety, or depression. These symptoms improve within a few days after the period starts, but they can be severe enough to interfere with life.

Global Premenstrual Dysphoric Disorder (PMDD) Market Segmentation

Regional Research Reports has segmented the global Premenstrual Dysphoric Disorder (PMDD) market based on treatment, diagnosis, and end user at a regional and global level. Geographically, the research report has considered the five regions: North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Moreover, the research study focuses on the market analysis of the tier-1 countries, such as the USA, China, Germany, India, the UK, Japan, France, Italy, Spain, Russia, South Korea, and other territories.

Global Premenstrual Dysphoric Disorder (PMDD) Market Analysis by Treatment

• Antidepressants
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Analgesics
• Hormone Therapy
• Exercise
• Diet
• Others

Global Premenstrual Dysphoric Disorder (PMDD) Market Analysis by Diagnosis

• Physical Examination
• Others

Global Premenstrual Dysphoric Disorder (PMDD) Market Analysis by End User

• Hospitals & Clinics
• Treatment Centers
• Others

Global Premenstrual Dysphoric Disorder (PMDD) Market Growth, by Region and Country, 2018-2021, 2022-2030 (US$ Millions)

Global Premenstrual Dysphoric Disorder (PMDD) Market Analysis by Region and Country

• North America (US, Canada, Mexico)
• Europe (Germany, UK, France, Italy, Spain, Russia, Switzerland, Poland, Belgium, the Netherlands, Norway, Sweden, Czech Republic, Slovakia, Slovenia, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Malaysia, Vietnam, Singapore, Australia & New Zealand, Rest of Asia Pacific)
• South America (Brazil, Argentina, Peru, Colombia, Rest of South America)
• The Middle East & Africa (UAE, Saudi Arabia, South Africa, Egypt, Qatar, Northern Africa, Rest of MEA)

Global Premenstrual Dysphoric Disorder (PMDD) Market Competitive: Key Players

The report includes a comprehensive analysis of leading market players, such as:

• Key companies Premenstrual Dysphoric Disorder (PMDD) revenues in the global market, 2018-2021 (Estimated), (US$ Millions)
• Key companies Premenstrual Dysphoric Disorder (PMDD) revenues market share in global market, 2021 (%)
• Key companies Premenstrual Dysphoric Disorder (PMDD) sold in the global market, 2018-2021 (Estimated)

Leading Premenstrual Dysphoric Disorder (PMDD) Manufacturers –

• Pfizer Inc.
• Bristol-Myers Squibb Company
• Merck Sharp & Dohme Corp.
• Novartis AG
• Cipla Inc.
• GlaxoSmithKline plc
• Teva Pharmaceutical Industries Ltd.
• Eli Lilly and Company
• AstraZeneca
• Johnson & Johnson Private Limited
• Sanofi
• Bayer AG
• Sun Pharmaceutical Industries Ltd.
• Apotex Inc.
• Mylan N.V.
• Allergan
• Takeda Pharmaceutical Company Limited.
• Sumitomo Dainippon Pharma Co., Ltd.
• AbbVie Inc.
• Dr. Reddy’s Laboratories Ltd.
• Lupin
• Bausch Health Companies Inc

(Note: The list of the key market players can be updated with the latest market scenario and trends)

Premenstrual Dysphoric Disorder (PMDD) Market Report Covers Comprehensive Analysis On:

• Market Segmentation & Regional Analysis
• Market Size of 10 years
• Pricing Analysis
• Supply & Demand Analysis
• Treatment Life Cycle Analysis
• Porter's Five Forces & Value/Supply Chain Analysis
• Developed & Emerging Economies Analysis
• PESTEL Analysis
• Market and Forecast Factor Analysis
• Market Opportunities, Risks, & Trends
• Conclusion & Recommendation
• Regulatory Landscape
• Patent Analysis
• Competition Landscape
• 15+ Company Profiles

Report Scope and Details

Premenstrual Dysphoric Disorder (PMDD) Market Research Methodology

The report is based on analysis through extensive secondary research and primary Interviews.

The secondary data sources include the company website, annual reports, investor presentations, press releases, white papers, journals, certified publications, government websites, and articles from the industry.

Similarly following is the list of a few paid secondary sources/databases,

• Factiva
• Statista
• D&B Hoovers
• Owler
• Enlyft
• HG Insights
• Bloomberg
• Crunchbase

The primary sources include CXOs, VPs, directors, technology & innovation directors, treatment managers, and related executives from key organizations from both the supply and demand sides. Similarly, we have also interviewed various end user organizations. We cannot reveal the end-user organizations due to non-disclosure agreements.

For instance, the region forecast is based on extensive secondary research and primary Interviews. We have conducted primary interviews across the regions to get more region-specific insights. Additionally, primary interviews were conducted with independent consultants and subject matter experts in respective regions. These experts were interviewed to obtain qualitative and quantitative information related to the market and validate the research findings and estimations. The primary and secondary data inputs referred for triangulation and forecast for the region segment are as follows,

• Top Player's historic revenues and Year on Year Growth
• Top Players' regional presence and revenue patterns
• Recent Developments and strategies of vendors and end users (E.g., Mergers & Acquisitions, Partnerships, New Treatment launches, and others)
• R&D Investments & Innovation Landscape
• Start-up Ecosystem and Funding Initiatives
• Regulatory Environment and Implications (Country or region Specific)

Benefits of purchasing this report:

• We have an easy delivery model, where you can suggest changes and customize the report's scope and table of content as per your needs and requirements
• The 20% of the customization in this market is offered free of charge with the purchase of any license of the report
• You can also directly share your query purpose for this report while requesting to sample request or buying this study
• 130+ pages in the PDF printable format and Editable Excel Sheet
• Free 60 Days Analyst support to explain your feedback during post-purchase
• Conclusion and recommendation to assist in implementing the report's benefits at the ground level